Hemodialysis care. Encounter for care involving renal dialysis
Conditions
Interventions
Interventions: Initially, all participants will undergo a two-week monitoring period without any intervention. Following this, the levels of Xerostomia and Thirst will be measured using specific instr
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years Patients with a definitive diagnosis of end-stage kidney disease based on medical records Treated with hemodialysis three times a week or more regularly Feeling of dry mouth in the last four weeks Fully alert and having the ability to communicate verbally Having natural teeth and the ability to chew gum Absence of mouth ulcers Having a personal mobile phone or the ability to read text messages Absence of liver and biliary disorders and digestive refluxes Patients who like the taste of mint Not having habits of chewing gum continuously Answer frequently or always according to the standard question, "How often does your mouth feel dry?"
Exclusion criteria
Exclusion criteria: Having head and neck cancer Not being able to chew gum and not using it Patients who change their hemodialysis center during the study period Patient participation in another similar study Death of the patient Patients who change their treatment method
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Xerostomia. Timepoint: The study will be evaluated Xerostomia before and after each period (The first two weeks, The second two weeks, The third two weeks, The fourth two weeks). T0: Before commencing the study, all patients undergo a two-week control period without any intervention. T1: End of the first two weeks (control period) T2: After the second two-week period, sequence A will be receive intervention 1 (Peppermint Pistacia atlantica gum) and sequence B will receive intervention 2 (Pure Pistacia atlantica gum). T3: End of the third two weeks (Washout) T4: End of the fourth two weeks sequence B will be receive intervention 1 (Peppermint Pistacia atlantica gum) and sequence A will receive intervention 2 (Pure Pistacia atlantica gum). Method of measurement: Shortening Xerostomia Inventory (SXI).;Thirst. Timepoint: The study will be evaluated Thirst before and after each period (The first two weeks, The second two weeks, The third two weeks, The fourth two weeks). T0: Before commencing the study, all patients undergo a two-week control period without any intervention. T1: End of the first two weeks (control period) T2: After the second two-week period, sequence A will be receive intervention 1 (Peppermint Pistacia atlantica gum) and sequence B will receive intervention 2 (Pure Pistacia atlantica gum). T3: End of the third two weeks (Washout) T4: End of the fourth two weeks sequence B will be receive intervention 1 (Peppermint Pistacia atlantica gum) and sequence A will receive intervention 2 (Pure Pistacia atlantica gum). Method of measurement: Dialysis Thirst Inventory (DTI). | — |
Secondary
| Measure | Time frame |
|---|---|
| Intra Dialysis Weight Gain (IDWG). Timepoint: The study will be evaluated Intra Dialysis Weight Gain (IDWG) before and after each period (The first two weeks, The second two weeks, The third two weeks, The fourth two weeks). T0: Before commencing the study, all patients undergo a two-week control period without any intervention. T1: End of the first two weeks (control period) T2: After the second two-week period, sequence A will be receive intervention 1 (Peppermint Pistacia atlantica gum) and sequence B will receive intervention 2 (Pure Pistacia atlantica gum). T3: End of the third two weeks (Washout) T4: End of the fourth two weeks sequence B will be receive intervention 1 (Peppermint Pistacia atlantica gum) and sequence A will receive intervention 2 (Pure Pistacia atlantica gum). Method of measurement: Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMansoor ghafourifard
Tabriz University of Medical Sciences
Outcome results
None listed